-
Product Insights
Hearing Disorders – Drugs In Development, 2023
Global Markets Direct’s, ‘Hearing Disorders - Drugs In Development, 2023’, provides an overview of the Hearing Disorders pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hearing Disorders, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...
-
Product Insights
Acute Sensorineural Hearing Loss – Drugs In Development, 2023
Global Markets Direct’s, ‘Acute Sensorineural Hearing Loss - Drugs In Development, 2023’, provides an overview of the Acute Sensorineural Hearing Loss pipeline landscape. The report provides comprehensive information on the therapeutics under development for Acute Sensorineural Hearing Loss, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press...
-
Company Profile
Sensorion SA – Company Profile
Sensorion SA (Sensorion) is a pharmaceutical company that develops therapies. The company provides treatments for vestibular and cochlear pathologies. Its pipeline products includes OTOF-GT, USHER-GT, SENS-401 and GJB2-GT. Sensorion develops drug candidates through its technology platform for the treatment of various therapeutic areas including vestibular neuritis, acute vertigo, meniere’s disease, migraine-associated vertigo, benign paroxysmal positional vertigo, vestibular lesions and tinnitus, and ototoxicity. It also offers a clinical trial with SENS-401, a class drug to treat sudden sensori neural hearing loss...
Add to Basket -
Product Insights
Tinnitus Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
The Tinnitus pipeline market report provides a comprehensive overview of the therapeutics under development for Tinnitus, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Tinnitus and features dormant and discontinued...
-
Product Insights
Histamine H4 Receptor (AXOR35 or G Protein Coupled Receptor 105 or GPRv53 or Pfi-013 or SP9144 or GPCR105 or HRH4) Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players, 2022 Update
The histamine H4 receptor (HRH4) modulates eosinophil migration and selective recruitment of mast cells leading to amplification of histamine-mediated immune responses and eventually to chronic inflammation. H4 receptor involvement in dendritic cell activation and T cell differentiation documents its immunomodulatory function. The HRH4 pipeline market research report provides comprehensive information on the HRH4 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive...
-
Sector Analysis
Outlook for Viral Vector Contract Manufacturing – Gene Therapies, Cell Therapies, and COVID-19 Vaccines
The bio/pharmaceutical industry is experiencing a shortage of viral vectors, a component needed to produce gene therapies and gene-modified cell therapies, as well as certain COVID-19 vaccines that require a viral vector, notably those from AstraZeneca and Johnson & Johnson (J&J). This report reveals that viral vector production is limited by insufficient manufacturing capacity, an inefficient manufacturing process, and the requirement for complex specialist facilities. There are 14 therapies/vaccines that use a viral vector (gene therapies, gene-modified cell therapies, and...
-
Product Insights
Hearing Disorders Disease – Global Clinical Trials Review, H2, 2020
GlobalData's clinical trial report, “Hearing Disorders Global Clinical Trials Review, H2, 2020" provides an overview of Hearing Disorders Clinical trials scenario. This report provides top line data relating to the clinical trials on Hearing Disorders. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Hearing Disorders Disease – Global Clinical Trials Review, H1 2020
GlobalData's clinical trial report, “Hearing Disorders Global Clinical Trials Review, H1, 2020" provides an overview of Hearing Disorders Clinical trials scenario. This report provides top line data relating to the clinical trials on Hearing Disorders. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent...
-
Product Insights
Deafness Disease – Global Clinical Trials Review, H1 2019
GlobalData's clinical trial report, “Deafness Global Clinical Trials Review, H1, 2019" provides an overview of Deafness clinical trials scenario. This report provides top line data relating to the clinical trials on Deafness. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress...
-
Product Insights
Acute Sensorineural Hearing Loss Global Clinical Trials Review, H2, 2018
GlobalData's clinical trial report, “Acute Sensorineural Hearing Loss Global Clinical Trials Review, H2, 2018" provides an overview of Acute Sensorineural Hearing Loss clinical trials scenario. This report provides top line data relating to the clinical trials on Acute Sensorineural Hearing Loss. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and...